Table 1.
Demographics and baseline characteristics of Indian women living with HIV
| Intent-to-treat# N (%) | Per-protocol& N (%) | |
|---|---|---|
| Number of participants | 150 (100) | 126 (100) |
| Group | ||
| 1 – CD4 nadir≤ 350, on HAART | 49 (32.7) | 47 (37.3) |
| 2 – CD4 nadir>350, current CD4 350–500, not on HAART | 50 (33.3) | 33 (26.2) |
| 3 – CD4 nadir>350, current CD4 >500, not on HAART | 51 (34.0) | 46 (36.5) |
| Age in years | ||
| Mean (±SD) | 30.8±5.2 | 31.2±5.1 |
| Median (IQR) | 30.0 (27–34) | 30.5 (28–34) |
| CDC HIV Risk Group | ||
| Homosexual contact | 0 | 0 |
| Heterosexual contact | 147 (98.0) | 124 (98.4) |
| IV drug user | 0 | 0 |
| Transfusion recipient | 1 (0.7) | 1 (0.7) |
| Other – health care worker | 1 (0.7) | 1 (0.7) |
| Unknown | 1 (0.7) | 0 |
| CD4 level (cells/mm 3 ) | ||
| Mean (±SD) | 538.7±257.7 | 552.2±272.4 |
| Median (IQR) | 484.5 (390–686) | 504.5 (390–704) |
| HIV VL (copies/ mm 3 ) | ||
| Geometric Mean (95% CI) | 6967 (4722–10279) | 5393 (3533–8235) |
| Median (IQR) | 7440 (400–52800) | 5600 (400–36000) |
*
1 participant missing HIV VL at baseline and 1 participant had an undetectable HIV VL (<400 copies/mL) at baseline.
#
Intent to treat population: all women who received at least one vaccination injection
&
Per-protocol population: women who were eligible, received all vaccinations, and attended all protocol visits